Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NT5E | P21589 | 9/20 | 0.81 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.81 |
| ▸ | PRKCG | P05129 | 2/20 | 0.79 |
| ▸ | CETP | P11597 | 1/20 | 0.78 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.77 |
| ▸ | USP2 | O75604 | 1/20 | 0.76 |
| ▸ | LMNA | P02545 | 1/20 | 0.76 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.76 |
| ▸ | AKR1B10 | O60218 | 1/20 | 0.76 |
| ▸ | ALB | P02768 | 1/20 | 0.76 |
| ▸ | POLB | P06746 | 1/20 | 0.76 |
| ▸ | GLI1 | P08151 | 1/20 | 0.76 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.76 |
| ▸ | DPP4 | P27487 | 1/20 | 0.76 |
| ▸ | RORC | P51449 | 1/20 | 0.76 |
| ▸ | GPBAR1 | Q8TDU6 | 1/20 | 0.76 |
| ▸ | SAE1 | Q9UBE0 | 1/20 | 0.76 |
| ▸ | UBA2 | Q9UBT2 | 1/20 | 0.76 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25749156 | 1.00 | NT5E (0.81) | NT5EPRKCDPRKCGCETPPTPN1 | |
| SCHEMBL16671401 | 1.00 | NT5E (0.81) | NT5EPRKCDPRKCGCETPPTPN1 | |
| SCHEMBL10214498 | 1.00 | NT5E (0.81) | NT5EPRKCDPRKCGCETPPTPN1 | |
| SCHEMBL9127145 | 1.00 | NT5E (0.81) | NT5EPRKCDPRKCGCETPPTPN1 | |
| SCHEMBL10214450 | 1.00 | NT5E (0.81) | NT5EPRKCDPRKCGCETPPTPN1 | |
| SCHEMBL13890817 | 1.00 | NT5E (0.81) | NT5EPRKCDPRKCGCETPPTPN1 | |
| SCHEMBL23626136 | 1.00 | NT5E (0.81) | NT5EPRKCDPRKCGCETPPTPN1 | |
| SCHEMBL960045 | 1.00 | NT5E (0.81) | NT5EPRKCDPRKCGCETPPTPN1 | |
| SCHEMBL12557823 | 1.00 | NT5E (0.81) | NT5EPRKCDPRKCGCETPPTPN1 | |
| SCHEMBL962020 | 1.00 | NT5E (0.81) | NT5EPRKCDPRKCGCETPPTPN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090275583-A1 | ANTIVIRAL COMPOUNDS AND USE THEREOF | MYRIAD GENETICS, INCORPORATED (US) | 2009-11-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090275583-A1 | ANTIVIRAL COMPOUNDS AND USE THEREOF | MAVS, ZC3HAV1, EIF2AK2 | NT5E 304/4885PRKCD 4241/4885PRKCG 3834/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.